Persistent URL of this record https://hdl.handle.net/1887/116147
Documents
-
- Download
- 10.1002-art.40196
- Not Applicable (or Unknown)
-
open access
In Collections
This item can be found in the following collections:
A Phase III Study Evaluating Continuation, Tapering, and Withdrawal of Certolizumab Pegol After One Year of Therapy in Patients With Early Rheumatoid Arthritis
- All authors
- Weinblatt, M.E.; Bingham, C.O.; Burmester, G.R.; Bykerk, V.P.; Furst, D.E.; Mariette, X.; Heijde, D. van der; Vollenhoven, R. van; VanLunen, B.; Ecoffet, C.; Cioffi, C.; Emery, P.
- Date
- 2017-10-31
- Journal
- Arthritis and Rheumatology
- Volume
- 69
- Issue
- 10
- Pages
- 1937 - 1948